As the market witnesses a relief rally this April, investors are turning toward stocks with strong momentum and analyst backing. For those looking for long‑term stability or short‑term growth, here are the three best trending stocks to follow today, April 16, 2026.
Claim 30% Off TipRanks
New trading tool for AMZN bullsTipRanks’ Trending Stocks tool allows users to filter activity over the past 30 days, seven days, or even the last 72 hours to see which stocks are drawing the most attention. Checking this page regularly can help you stay ahead of the latest market movers.
Here are the top three most‑rated stocks over the past 72 hours (listed in descending order). Click any ticker to explore all of TipRanks’ unique datasets for that stock.
Revolution Medicines (RVMD) – This clinical-stage biotech firm develops targeted cancer therapies, particularly for hard-to-treat RAS-driven tumors. RVMD stock has been rated by 12 analysts in the past three days. This flood of ratings came after the company filed to sell $250 million of convertible senior notes and $750 million of common stock.
The analyst consensus on the stock is a Strong Buy. With an average price target of $155.88, the stock has an implied upside potential of 4.88%.
Spyre Therapeutics (SYRE) – This clinical-stage biotech company is focused on developing next-generation antibody therapies for inflammatory bowel disease and other immune-mediated conditions. The stock is also trending, having been rated 12 times in the past 72 hours. The ratings came after Spyre reported strong Phase 2 SPY001 data in ulcerative colitis, with significant efficacy and clean safety.
The analyst consensus on the stock is a Strong Buy, with an average price target of $37.53, suggesting a downside risk of 7.13%.
Amazon (AMZN) – This global technology leader dominates online retail and cloud services through AWS while expanding into AI, logistics, and digital media. The stock has received 12 ratings over the past 72 hours after the company announced a deal to acquire Globalstar (GSAT).
It earned an analyst consensus of Strong Buy and carries an average price target of $284.76, indicating a 14.59% upside potential.